Full Text View
Tabular View
No Study Results Posted
Related Studies
Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients
This study has been completed.
Study NCT00299091   Information provided by Germans Trias i Pujol Hospital
First Received: March 3, 2006   Last Updated: October 14, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV
Interventions listed in this trial
Efavirenz capsules 600 mg
Additional drug interventions recognized in this trial
Efavirenz
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Reverse Transcriptase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Germans Trias i Pujol Hospital
FUNDACIÓ LLUITA CONTRA LA SIDA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services